Cite
HARVARD Citation
van Wilpe, S. et al. (2022). Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype. Oncoimmunology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
van Wilpe, S. et al. (2022). Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype. Oncoimmunology. p. . [Online].